Calyx Seeking to Diversify Business Interests

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") is
providing this corporate update further to the update issued on March 31, 2014.


Calyx is an agricultural technology company that has been focused on the
renewable fuels sector through an investment interest in Agrisoma Biosciences
Inc. ("Agrisoma"). In light of ongoing challenges related to the funding of
Agrisoma in a way that is beneficial to all Agrisoma stakeholders, Calyx is
seeking to diversify its business interests and is reviewing businesses in the
tech, agriculture and biotech sectors including the MMPR (Marijuana for Medical
Purposes Regulations) and the agri-pharmaceutical space.


The medical marijuana industry is an emerging multibillion-dollar opportunity
and is undergoing significant regulatory and legal reform that offers strong
growth opportunities to early participants. Calyx is considering entry into this
arena. New medical marijuana licensing that came into effect April 1, 2014 will
allow for licensed producers to now grow on a larger, commercial scale.


The medical marijuana industry is in its infancy as a legitimate corporate
industry. Estimates by Health Canada and ArcView Angel Investors are that the
sector will grow 10 fold and become an industry of more than a $10 billion
annually over the next 5 years.


Calyx is currently in discussions for and is completing initial reviews of a
number of potential new business opportunities and will continue to provide
further updates as necessary.


About Calyx 

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
focused on renewable fuels including biojet and biodiesel. Calyx is the largest
shareholder of Agrisoma Biosciences Inc., a company which is producing a new
proprietary non-food energy feedstock crop - carinata - which yields oil that
can be refined into fuels that work in existing engines as a 100 percent
petroleum substitute. From seed to sky, fuels produced from carinata
substantially reduce carbon and other harmful emissions, and help to reduce
global petroleum dependence. Carinata was used to fly the world's first 100%
biojet flight, as achievement that Popular Science called one of the top science
events on the planet in 2012. For further information about Calyx, please visit
www.calyxbio.com. For more information on Agrisoma, please visit
www.agrisoma.com. 


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx, as well as other expectations, plans, goals,
objectives, information or statements about future events, conditions, or
performance that may constitute "forward-looking statements" or "forward-looking
information" under applicable securities legislation. Such statements or
information involve substantial known and unknown risks and uncertainties,
certain of which are beyond Calyx's control. 


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect.


Although Calyx believes that the expectations reflected in such forward-looking
statements or information are reasonable, undue reliance should not be placed on
forward-looking statements because Calyx can give no assurance that such
expectations will prove to be correct. Forward-looking statements or information
are based on current expectations, estimates and projections that involve a
number of risks and uncertainties which could cause actual results to differ
materially from those anticipated by Calyx and described in the forward-looking
statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx undertakes no obligation to update publicly
or revise any forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by applicable
securities laws or the TSX Venture Exchange. The forward-looking statements or
information contained in this news release are expressly qualified by this
cautionary statement.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures Inc.
Don Konantz
President & CEO
604-649-5961
dkonantz@calyxbio.com


Calyx Bio-Ventures Inc.
Investor Relations:
Keir Reynolds
778-998-9242
kreynolds@calyxbio.com
www.calyxbio.com
Calyx Ventures (TSXV:CYX)
過去株価チャート
から 5 2024 まで 6 2024